Author  
Place of duty  
Title   À§ÀüÀýÁ¦¼úÀ» ½ÃÇàÇÑ À§¾Ï 123 ¿¹¿¡ ´ëÇÑ ÀÓ»óÀû ºÐ¼® ( Clinical Analysis of 123 Cases of Total Gastrectomy in the Treatment of Stomach Cancer )
Publicationinfo   1992 Jan; 024(02): 293-306.
Key_word   Stomach cancer, Total and extended total gastrectomy
Full-Text  
Abstract   In order to identify the tendency of annual incidences of gastric cancer and the rate of total and extended total gastrectomy and to evaluate the preoperative diagnostic methods(UGI series, abdominal ultrasonography and CT) for determination of resectability and to analyse the complications according to jejunal reconstructive types, authors analysed the patients who underwent total and extended total gastrectomy in Korea Cancer Center Hospital during the period from January, 19S4 to December, 1989. Durink the period a series of 1,766 paients with gastric malignancy underwent surgery at Korea Cancer Center HospitaL Of these, total and extended total gastrectomy were performed in 144(8.2%) patients and complete follow-up was done in 123 cases(follow-up rate: 85.4%). The results were as follows: I) The rates of total and extended total aastrectomy showed increasing tendency year by year. 2) Blood type A seemed to be risky group for gastric cancer(p<0.0001). 3) The overall accuracy of UGI, abdominal CT and USG for determination of preoperative resectability were 63.8%, 58.9/ and 39.5/, respectively. 4) The incidences of postoperative reflux esophagitis were 13.3%, 18.2% and 24.4/ according to fundic tubojejunostomy(PAIK's procedure) with Braun anastomosis, Roux en Y esophagoxjunostomy and loop esophagojejunostomy with Braun anastomosis, respectively. 5) The incidences of dumping syndrome were 6.7%, 13.6/ and 7.0% according to fundic tubojejunostomy with Braun anastomosis, Roux en Y esophagojejunostomy and loop esophagojejunostomy with Braun anastomosis, respectively. 6) Postoperative complication rate was 9.0%(13/123). Lung problem was the most common complication. Operation mortality was 2.4%(3/123). 7) Five year survival rates were 87.5%, 77.7%, 43.8% and 8.8% according to stage I, II, III and IV, respectively.
Àú ÀÚ   ±Ç⿵(Chang Young Kwon),¹é³²¼±(Nam Sun Paik),ÀÌÁ¾ÀÎ(Jong Inn Lee)